Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage; D000328:Adult; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008750:Methyldopa / Q000008:administration & dosage; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D010648:Phenylacetates / Q000134:cerebrospinal fluid*
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D006834:Hydrazines; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan